Login / Signup

Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report.

Elisabetta BussalinoAndrea De MariaRodolfo RussoErnesto Paoletti
Published in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2020)
The role of systemic inflammation is proving crucial in determining unfavorable outcome in SARS-CoV-2-infected patients. Limited data are available regarding immunosuppression management in kidney transplant recipients (KTRs) with SARS-CoV-2 pneumonia. We report a case of a 32-year-old KTR who developed SARS-CoV-2 infection and fully recovered in 15 days while maintaining standard immunosuppressive therapy.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • electronic health record
  • machine learning
  • big data
  • mesenchymal stem cells
  • acute respiratory distress syndrome
  • extracorporeal membrane oxygenation